Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement | Psychedelic Invest
Clearmind Medicine Inc. (NASDAQ: CMND) (the “Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems,